Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cromoglycate
Drug ID BADD_D00537
Description A chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack.
Indications and Usage For the management of patients with bronchial asthma. Also used in the treatment of vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis.
Marketing Status Prescription; OTC; Discontinued
ATC Code A07EB01; D11AH03; R01AC01; R03BC01; S01GX01
DrugBank ID DB01003
KEGG ID D07753
MeSH ID D004205
PubChem ID 2882
TTD Drug ID D0G7IY
NDC Product Code Not Available
Synonyms Cromolyn Sodium | Sodium Cromoglycate | Cromoglycate, Sodium | Disodium Cromoglycate | Cromoglycate, Disodium | Aarane | Bicromat Spray | Cromoglycate | Opticrom | FPL-670 | FPL 670 | FPL670 | Intal | Lomudal | Nalcrom | Nasalcrom | Vicrom | Cromolyn | Cromoglicic Acid | Acid, Cromoglicic | Cromoglycic Acid | Acid, Cromoglycic
Chemical Information
Molecular Formula C23H16O11
CAS Registry Number 16110-51-3
SMILES C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)O)O)C(=O)C=C(O2)C(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Nervousness19.06.02.003--Not Available
Neuritis17.09.03.001--Not Available
Neuropathy peripheral17.09.03.003--Not Available
Neutropenia01.02.03.004--Not Available
Oedema14.05.06.010; 08.01.07.006--Not Available
Oesophageal spasm07.02.04.004--Not Available
Pain08.01.08.004--
Palpitations02.01.02.003--
Pancytopenia01.03.03.003--Not Available
Paraesthesia17.02.06.005--
Pericarditis02.06.02.001--
Pharyngitis22.07.03.004; 11.01.13.003; 07.05.07.004--
Photosensitivity reaction23.03.09.003--
Pollakiuria20.02.02.007--
Polycythaemia01.07.01.001--Not Available
Polymyositis15.05.01.004; 10.04.05.004--Not Available
Purpura24.07.06.005; 23.06.01.004; 01.01.04.003--
Rash23.03.13.001--Not Available
Rash maculo-papular23.03.13.004--
Seizure17.12.03.001--
Serum sickness12.02.08.004; 10.01.03.004--
Sneezing22.02.05.011--
Somnolence19.02.05.003; 17.02.04.006--
Stomatitis07.05.06.005--
Swelling08.01.03.015--Not Available
Systemic lupus erythematosus23.03.02.006; 15.06.02.003; 10.04.03.004--Not Available
Tachycardia02.03.02.007--Not Available
Tension19.06.02.005--Not Available
Throat irritation22.02.05.013; 07.05.03.004--Not Available
Tinnitus17.04.07.004; 04.04.01.002--
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages